BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Verum.de CEO to Present on International Clinical Trial Regulations at BIOCOMEvent


11/12/2012 9:24:18 AM

SAN DIEGO, Nov. 9, 2012 /PRNewswire/ -- The CEO of Verum.de (Verum), a full-clinical service, German-based contract research organization (CRO) with a new office in Carlsbad, Calif. will speak at an upcoming event held by BIOCOM, the large regional life science association, on Tuesday, Nov. 13, 2012 at 7:30 a.m. PST. The session, Legal and Regulatory Update - Health Care Reform and FDA Developments, will feature Verum CEO Christian Sacher presenting about the clinical trial approval process in the European Union and the proposed changes to the EU trial regulations.

(Logo: http://photos.prnewswire.com/prnh/20120807/LA53176LOGO)

Verum joined BIOCOM earlier this year to expand awareness of its flexible and responsive services and its ability to run clinical trial services with Western standards in Central and Eastern European countries (CEE) and former Soviet bloc countries. With more than 25 years experience running clinical trials in Eastern Europe, Sacher is considered a pioneer in the industry. He helped bring ethical committees and Western best practices to trials in the region.

"It is an honor to have the opportunity to speak at BIOCOM as the organization mirrors Verum's values regarding clinical trials," says Christian Sacher. "With both FDA and European regulations constantly changing, we need to help biotech, pharma and device companies stay on top of the latest developments."

Verum recently opened a U.S. office in Carlsbad to assist U.S. clients with international trials. The new office is headed by Kristi Clark, an industry veteran with more than 20 years of pharma and biotech experience in both large and mid-size CROs.

About Verum.de

German-based Verum.de was founded by Christian Sacher and Jutta Minkner (CFO), two industry pioneers with more than 25 years experience running clinical trials in CEE and former Soviet bloc countries. Verum has more than 100 office based employees operating out of eight locations, including its Munich headquarters, and the company offers therapeutic specialties in cardiovascular, neurology, psychiatry, CNS, oncology and pain, among others. Verum started operations in 1992 in CEE countries based on Western ideals and ethical standards. Verum has substantial contacts with local authorities, and is known in CEE for the flexible and responsive services it provides. More information can be found at http://www.verum.de

CONTACT:

Antonia Genov
Clearpoint Agency, for Verum.de
antonia@clearpointagency.com
760-230-2424

SOURCE Verum.de



Read at BioSpace.com

BIOCOM
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES